Biologic medicines have transformed treatment for numerous chronic and life-threatening conditions such as cancer, ...

We spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The second part of our conversation with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and ...

One of the largest healthcare companies in India, Abbott sells a wide range of products, including medicines, nutrition, ...

UBS analysts maintained a Buy rating for Alvotech SA (NASDAQ:ALVO) with a steady price target of $18.00, representing a 41% ...

Biosimilars Market Poised for Rapid Growth, Driven by Advancements in Therapeutics and Expanding Patient AccessPune, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Global Biosimilars Market Size & Growth Analysis: ...

The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has ...

Biocon is set for major growth in the next 2-3 years, propelled by new generics and biosimilars. The Viatris acquisition ...

Panelists discuss how biosimilars have significantly reduced health care costs in the US, with health care systems experiencing significant savings across various therapeutic areas. These cost ...

Biocon plans to list its biosimilars business by March 2026, targeting a double-digit market share in the U.S. with five new launches. The company aims to complete its integration with Viatris and ...